Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.
- DOI
- 10.1136/rmdopen-2025-005433
- Published
- 2025 Aug 12
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2025-005433,
title = {Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.},
author = {Henrotin Y and Pap T and Lieten S and Badot V and Dubuc JE and Urbin-Choffray D and von Eynatten M and Johansen OE and Rau S and Brabants K},
year = {2025},
journal = {RMD open},
doi = {10.1136/rmdopen-2025-005433},
url = {https://doi.org/10.1136/rmdopen-2025-005433}
}RIS
TY - JOUR TI - Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial. AU - Henrotin Y AU - Pap T AU - Lieten S AU - Badot V AU - Dubuc JE AU - Urbin-Choffray D AU - von Eynatten M AU - Johansen OE AU - Rau S AU - Brabants K PY - 2025 JO - RMD open DO - 10.1136/rmdopen-2025-005433 UR - https://doi.org/10.1136/rmdopen-2025-005433 ER -
APA
Y, H., T, P., S, L., V, B., JE, D., D, U., M, V. E., OE, J., S, R., & K, B. (2025). Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial.. RMD open. https://doi.org/10.1136/rmdopen-2025-005433
Source records
- pubmed · retrieved 2026-09-26T12:04:17.652Z